Ganciclovir-mediated elimination of HSV-Tk + T cells and cure of graft-vs-host disease in an allogeneic bone marrow transplantation model in the rat

Experimental Hematology

Volumn 32, Issue 10, 2004, Pages 962-969

  Weijtens, Mo ^a   Van Spronsen, Anke ^a   Hagenbeek, Anton ^a   De Weger, Roel ^b   Martens, Anton ^a,b  

^a Department of Hematology   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GANCICLOVIR; RETROVIRUS VECTOR; TACROLIMUS; THYMIDINE KINASE;

ALLOGENIC BONE MARROW TRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BLOOD; BONE MARROW TRANSPLANTATION; CONFERENCE PAPER; CONTROLLED STUDY; CYTOLYSIS; FEASIBILITY STUDY; GENETIC CODE; GRAFT VERSUS HOST REACTION; HERPES SIMPLEX VIRUS; LYMPHOCYTE DEPLETION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SUICIDE GENE THERAPY; SURVIVAL; T LYMPHOCYTE;

ANIMALS; BONE MARROW TRANSPLANTATION; GANCICLOVIR; GENE THERAPY; GENES, TRANSGENIC, SUICIDE; GRAFT VS HOST DISEASE; LYMPHOCYTE DEPLETION; MODELS, ANIMAL; RATS; RATS, INBRED STRAINS; T-LYMPHOCYTES; TRANSDUCTION, GENETIC; TRANSPLANTATION, HOMOLOGOUS;

ANIMALIA;

EID: 6944244100     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2004.07.009     Document Type: Conference Paper

References (32)

1. R. Champlin Immunobiology of bone marrow transplantation as treatment for hematologic malignancies Transplant Proc 23 1991 2123 2127
2. J.L. Ferrara, and H.J. Deeg Graft-vs-host disease N Engl J Med 324 1991 667 674
3. A.J. Barrett Mechanisms of the graft-vs-leukemia reaction Stem Cells 15 1997 248 258
4. H.J. Kolb, A. Schattenberg, and J.M. Goldman Graft-vs-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia Blood 86 5 1995 Sep1 2041 2050
5. S.M. Davies, C. Kollman, and C. Anasetti Engraftment and survival after unrelated-donor bone marrow transplantation: a report from the national marrow donor program Blood 96 2000 4096 4102
6. M.M. Horowitz, R.P. Gale, and P.M. Sondel Graft-vs-leukemia reactions after bone marrow transplantation Blood 75 1990 555 562
7. A.M. Marmont, M.M. Horowitz, and R.P. Gale T-cell depletion of HLA-identical transplants in leukemia Blood 78 1991 2120 2130
8. M.H. St. Clair, C.U. Lambe, and P.A. Furman Inhibition by ganciclovir of cell growth and DNA synthesis of cells biochemically transformed with herpesvirus genetic information Antimicrob Agents Chemother 31 1987 844 849
9. J.L. Cohen, M.-F Saron, and O. Boyer Preservation of graft-vs-infection effects after suicide gene therapy for prevention of graft-vs-host disease Hum Gene Ther 11 2000 2473 2481
10. P. Tiberghien, C.W. Reynolds, and J. Keller Ganciclovir treatment of herpes simplex thymidine kinase-transduced primary T lymphocytes: an approach for specific in vivo donor T-cell depletion after bone marrow transplantation? Blood 84 1994 1333 1341
11. J.L. Cohen, O. Boyer, and B. Salomon Prevention of graft-vs-host disease in mice using a suicide gene expressed in T lymphocytes Blood 89 1997 4636 4645
12. E. Contassot, C. Ferrand, and R. Angonin Ganciclovir-sensitive acute graft-vs-host disease in mice receiving herpes simplex virus-thymidine kinase-expressing donor T cells in a bone marrow transplantation setting Transplantation 69 2000 503 508
13. W.R. Drobyski, H.C. Morse 3rd, W.H. Burns, J.T. Casper, and G. Sandford Protection from lethal murine graft-vs-host disease without compromise of allo-engraftment using transgenic donor T cells expressing a thymidine kinase suicide gene Blood 97 2001 2506 2513
14. M.H.V. Lake-Bullock, J.S. Bryson, C.D. Jennings, and A.M. Kaplan Inhibition of graft-vs-host disease. Use of a T cell-controlled suicide gene J Immunol 158 1997 5079 5082
15. S.M. Kornblau, I. Stiouf, and V. Snell Preemptive control of graft-vs-host disease in a murine allogeneic transplant model using retrovirally transduced murine suicidal lymphocytes Cancer Res 61 2001 3355 3360
16. C. Bordignon, C. Bonini, and S. Verzeletti Transfer of the HSV-tk gene into donor peripheral blood lymphocytes for in vivo modulation of donor anti-tumor immunity after allogeneic bone marrow transplantation Hum Gene Ther 6 1995 813 819
17. C.J. Link Jr., R.K. Burt, and A.E. Traynor Adoptive immunotherapy for leukemia: donor lymphocytes transduced with the herpes simplex thymidine kinase gene for remission induction Hum Gene Ther 9 1998 115 134
18. P. Tiberghien Use of donor T-lymphocytes expressing herpes-simplex thymidine kinase in allogeneic bone marrow transplantation: A phase I-II study Hum Gene Ther 8 1997 615 624
19. C. Bonini, G. Ferrari, and S. Verzeletti HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-vs-leukemia Science 276 1997 1719 1724
20. P. Tiberghien, C. Ferrand, and B. Lioure Administration of herpes simplex-thymidine kinase-expressing donor T cells with a T-celldepleted allogeneic marrow graft Blood 97 2001 63 72
21. T.C. Kloosterman, M.J. Tielemans, A.C. Martens, D.W. van Bekkum, and A. Hagenbeek Quantitative studies on graft-vs-leukemia after allogeneic bone marrow transplantation in rat models for acute myelocytic and lymphocytic leukemia Bone Marrow Transplant 14 1994 15 22
22. M.E.M. Weijtens, A. van Spronsen, A. Hagenbeek, E. Braakman, and A.C.M. Martens Reduced graft-vs-host disease-inducing capacity of T cells after activation culturing and magnetic cell sorting selection in an allogeneic bone marrow transplantation model in rats Hum Gene Ther 13 2002 187 198
23. J.S. Gammie, S. Li, and Y.L. Colson A partial conditioning strategy for achieving mixed chimerism in the rat: tacrolimus and anti-lymphocyte serum substantially reduce the minimum radiation dose for engraftment Exp Hematol 26 1998 927 935
24. S. Maury, E. Litvinova, and O. Boyer Effect of combined cytostatic cyclosporin A and cytolytic suicide gene therapy on the prevention of experimental graft-vs-host disease Gene Ther 9 3 2002 Feb 201 207
25. T.C. Kloosterman, A.C. Martens, D.W. van Bekkum, and A. Hagenbeek Graft-vs-leukemia in rat MHC-mismatched bone marrow transplantation is merely an allogeneic effect Bone Marrow Transplant 15 1995 583 590
26. M.I. Garin, E. Garrett, and P. Tiberghien Molecular mechanism for ganciclovir resistance in human T lymphocytes transduced with retroviral vectors carrying the herpes simplex virus thymidine kinase gene Blood 97 2001 122 129
27. L. Weiss, I. Lubin, and I. Factorowich Effective graft-vs-leukemia effects independent of graft-vs-host disease after T cell-depleted allogeneic bone marrow transplantation in a murine model of B cell leukemia/lymphoma. Role of cell therapy and recombinant IL-2 J Immunol 153 6 1994 Sep 15 2562 2567
28. E. Litvinova, S. Maury, and O. Boyer Graft-vs-leukemia effect after suicide-gene-mediated control of graft-vs-host disease Blood 100 6 2002 Sep 15 2020 2025
29. S. Verzeletti, C. Bonini, and S. Marktel Herpes simplex virus thymidine kinase transfer for controlled graft-vs-host disease and graft-vs-leukemia: clinical follow-up and improved new vectors Hum Gene Ther 9 1998 2243 2251
30. I.F. Khouri, R.M. Saliba, and S.A. Giralt Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity acute graft-vs-host disease and treatment-related mortality Blood 98 2001 3595 3599
31. G.R. Hill, and J.L. Ferrara The primacy of the gastrointestinal tract as a target organ of acute graft-vs-host disease: rationale for the use of cytokine shields in allogeneic bone marrow transplantation Blood 95 2000 2754 2759
32. L.F. Verdonck, A.W. Dekker, G.C. de Gast, M.L. van Kempen, H.M. Lokhorst, and H.K. Nieuwenhuis Allogeneic bone marrow transplantation with a fixed low number of T cells in the marrow graft Blood 83 1994 3090 3096